These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline. Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321 [TBL] [Abstract][Full Text] [Related]
7. Betaxolol and timolol. Harrison R Arch Ophthalmol; 1984 Oct; 102(10):1424, 1426. PubMed ID: 6148923 [No Abstract] [Full Text] [Related]
8. Cardiovascular effects of befunolol, betaxolol and timolol eye drops. Dorigo MT; Cerin O; Fracasso G; Altafini R Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic effects of beta-blocking agents used in the management of glaucoma. James IM Surv Ophthalmol; 1989 Apr; 33 Suppl():453-4; discussion 459-60. PubMed ID: 2568696 [No Abstract] [Full Text] [Related]
10. Betaxolol vs timolol. A six-month double-blind comparison. Stewart RH; Kimbrough RL; Ward RL Arch Ophthalmol; 1986 Jan; 104(1):46-8. PubMed ID: 3510612 [TBL] [Abstract][Full Text] [Related]
11. Timolol maleate: side effects on healthy nonglaucomatous volunteers. Davidson J; Ribak J; Eckstein D; Barishak R Aviat Space Environ Med; 1983 Apr; 54(4):360-2. PubMed ID: 6133515 [TBL] [Abstract][Full Text] [Related]
12. Betaxolol and timolol. A comparison of efficacy and side effects. Berry DP; Van Buskirk EM; Shields MB Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723 [TBL] [Abstract][Full Text] [Related]
13. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension. Feghali JG; Kaufman PL; Radius RL; Mandell AI Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and pulmonary effects of beta-blocking agents: implications for their use in ophthalmology. Collignon P Surv Ophthalmol; 1989 Apr; 33 Suppl():455-6; discussion 459-60. PubMed ID: 2568697 [No Abstract] [Full Text] [Related]
15. Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs. Pillunat LE; Stodtmeister R Surv Ophthalmol; 1989 Apr; 33 Suppl():465-6; discussion 471-2. PubMed ID: 2568699 [No Abstract] [Full Text] [Related]
16. Drugs and glaucoma. Soll DB; Saxon AM Am Fam Physician; 1986 Jul; 34(1):181-5. PubMed ID: 2873739 [No Abstract] [Full Text] [Related]
17. Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients. Waldock A; Snape J; Graham CM Br J Ophthalmol; 2000 Jul; 84(7):710-3. PubMed ID: 10873979 [TBL] [Abstract][Full Text] [Related]
18. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers. Grieshaber MC; Flammer J Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652 [TBL] [Abstract][Full Text] [Related]
19. Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol. Lynch MG; Whitson JT; Brown RH; Nguyen H; Drake MM Arch Ophthalmol; 1988 Jul; 106(7):908-11. PubMed ID: 2898932 [TBL] [Abstract][Full Text] [Related]
20. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma. Berrospi AR; Leibowitz HM Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]